The endothelin-A receptor subtype transduces the effects of the endothelins in the anterior pituitary gland

https://doi.org/10.1016/0006-291X(92)91235-IGet rights and content

Abstract

All members of the mammalian endothelin family of peptides exert significant effects on prolactin and luteinizing hormone release from dispersed anterior pituitary cells in vitro. The rank order of potency for the prolactin inhibiting effects of the endothelins is ET-1=ET-2⪡ET-3. This suggests an involvement of the ET-A receptor subtype. The selective ET-A receptor antagonist BQ-123 antagonized the effects of the ETs in a competitive fashion with pA2 values of 6.1 (ET-1), 5.7 (ET-2) and 6.4 (ET-3), when added simultaneously with the ETs. This suggests the involvement of the ET-A receptor subtype in the actions of the ETs within the anterior pituitary gland.

References (18)

  • W.K. Samson et al.

    Biochem. Biophys. Res. Commun

    (1990)
  • B. Kanyicska et al.

    Biochem. Biophys. Res. Commun

    (1991)
  • M. Ihara et al.

    Life Sci

    (1992)
  • R.J. Tallarida et al.

    Life Sci

    (1979)
  • H. Matsumoto et al.

    Biochem. Biophys. Res. Commun

    (1989)
  • W.K. Samson et al.

    Regul. Peptides

    (1992)
  • W.K. Samson et al.

    Endocrinology

    (1992)
  • W.K. Samson et al.

    Endocrinology

    (1992)
  • H. Arai et al.

    Nature

    (1990)
There are more references available in the full text version of this article.

Cited by (0)

View full text